Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):762-767. doi: 10.1073/pnas.1719988115. Epub 2018 Jan 8.
Ig heavy chain (IgH) class switch recombination (CSR) in B lymphocytes switches IgH constant regions to change antibody functions. CSR is initiated by DNA double-strand breaks (DSBs) within a donor IgH switch (S) region and a downstream acceptor S region. CSR is completed by fusing donor and acceptor S region DSB ends by classical nonhomologous end-joining (C-NHEJ) and, in its absence, by alternative end-joining that is more biased to use longer junctional microhomologies (MHs). Deficiency for DSB response (DSBR) factors, including ataxia telangiectasia-mutated (ATM) and 53BP1, variably impair CSR end-joining, with 53BP1 deficiency having the greatest impact. However, studies of potential impact of DSBR factor deficiencies on MH-mediated CSR end-joining have been technically limited. We now use a robust DSB joining assay to elucidate impacts of deficiencies for DSBR factors on CSR and chromosomal translocation junctions in primary mouse B cells and CH12F3 B-lymphoma cells. Compared with wild-type, CSR and c-myc to S region translocation junctions in the absence of 53BP1, and, to a lesser extent, other DSBR factors, have increased MH utilization; indeed, 53BP1-deficient MH profiles resemble those associated with C-NHEJ deficiency. However, translocation junctions between DSB and general DSBs genome-wide are not MH-biased in ATM-deficient versus wild-type CH12F3 cells and are less biased in 53BP1- and C-NHEJ-deficient cells than CSR junctions or to S region translocation junctions. We discuss potential roles of DSBR factors in suppressing increased MH-mediated DSB end-joining and features of S regions that may render their DSBs prone to MH-biased end-joining in the absence of DSBR factors.
免疫球蛋白重链(IgH)类别转换重组(CSR)在 B 淋巴细胞中转换 IgH 恒定区以改变抗体功能。CSR 是由供体 IgH 开关(S)区和下游受体 S 区中的 DNA 双链断裂(DSB)引发的。CSR 通过经典非同源末端连接(C-NHEJ)融合供体和受体 S 区 DSB 末端完成,在缺乏 C-NHEJ 的情况下,通过更倾向于使用更长的连接微同源性(MH)的替代末端连接完成。DSB 反应(DSBR)因子的缺乏,包括共济失调毛细血管扩张突变(ATM)和 53BP1,会不同程度地损害 CSR 末端连接,而 53BP1 的缺乏影响最大。然而,DSBR 因子缺乏对 MH 介导的 CSR 末端连接的潜在影响的研究在技术上受到限制。我们现在使用一种强大的 DSB 连接测定法来阐明 DSBR 因子缺乏对初级小鼠 B 细胞和 CH12F3 B 淋巴瘤细胞中的 CSR 和染色体易位连接的影响。与野生型相比,在没有 53BP1 的情况下,CSR 和 c-myc 到 S 区易位连接以及在较小程度上,其他 DSBR 因子,增加了 MH 的利用;事实上,53BP1 缺陷型 MH 谱类似于与 C-NHEJ 缺陷相关的谱。然而,在 ATM 缺陷型与野生型 CH12F3 细胞中,全基因组范围内 DSB 和一般 DSB 之间的易位连接没有 MH 偏向性,并且在 53BP1 和 C-NHEJ 缺陷型细胞中,易位连接比 CSR 连接或 c-myc 到 S 区易位连接的 MH 偏向性更小。我们讨论了 DSBR 因子在抑制增加的 MH 介导的 DSB 末端连接中的潜在作用,以及 S 区的特征,这些特征可能使它们在缺乏 DSBR 因子的情况下容易发生 MH 偏向性末端连接。